Evidence map›Paper›PMID 16465184›Full record

ReviewBritish journal of pharmacology2006

In vitro models: research in physiology and pharmacology of the lower urinary tract.

Robert B Moreland

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 20 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Robert B MorelandNeuroscience Research, Global Pharmaceutical Research and Discovery, Department R4PM, Abbott Laboratories, Abbott Park, IL 60064-6123, USA. robert.moreland@abbott.com
Abbott (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The physiology and pharmacology of the lower urinary tract has advanced based, in part, due to the in vitro assays that have facilitated this exploration. Such assays have led to the development of novel and selective molecules that have been used to characterize different receptor and enzyme systems in the larger context of in vivo pharmacology. These assays can be classified by sites of action of drugs into the following categories: receptors, effector enzymes and enzymes that terminate the responses. In this review, representative assays are presented based on our experience in male erectile dysfunction.

Indexed as

Drug Evaluation, PreclinicalAnimalsBinding, CompetitiveCells, CulturedEnzyme-Linked Immunosorbent AssayErectile DysfunctionHumansIon ChannelsLigandsMaleMuscle ContractionMuscle, Smooth, VascularPenisRadioimmunoassayRadioligand AssayReceptors, Cell SurfaceIon ChannelsLigandsReceptors, Cell SurfaceReceptors, Cytoplasmic and Nuclear

Identifiers

PMID16465184
PMCPMC1751497
OpenAlexW2054873000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.